Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Olema Pharmaceuticals (OLMA) Gains from Sales and Divestitures (2020 - 2024)

Olema Pharmaceuticals (OLMA) has 5 years of Gains from Sales and Divestitures data on record, last reported at $92659.0 in Q4 2024.

  • On a quarterly basis, Gains from Sales and Divestitures fell 51.56% to $92659.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $92659.0, a 51.56% decrease, with the full-year FY2024 number at $92659.0, down 51.56% from a year prior.
  • Gains from Sales and Divestitures reached $92659.0 in Q4 2024 per OLMA's latest filing, roughly flat from $92659.0 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for OLMA hit a ceiling of $242109.0 in Q4 2021 and a floor of $6990.0 in Q1 2021.
  • A 5-year average of $94458.6 and a median of $73230.0 in 2020 define the central range for Gains from Sales and Divestitures.
  • Peak YoY movement for Gains from Sales and Divestitures: surged 616.66% in 2021, then crashed 74.42% in 2022.
  • Tracing OLMA's Gains from Sales and Divestitures over 5 years: stood at $53801.0 in 2020, then soared by 350.01% to $242109.0 in 2021, then decreased by 18.52% to $197274.0 in 2022, then decreased by 3.03% to $191296.0 in 2023, then crashed by 51.56% to $92659.0 in 2024.
  • Business Quant data shows Gains from Sales and Divestitures for OLMA at $92659.0 in Q4 2024, $92659.0 in Q3 2024, and $52308.0 in Q2 2024.